Jim Van Meerten's  Instablog

Jim Van Meerten
Send Message
Jim Van Meerten is an advisor to Marketocracy Capital Management and writes on financial subjects here and on Barchart Portfolio Blogs and Seeking Alpha. He earned a BS in Accounting and Business Administration from Berry College; a Juris Doctorate from the Woodrow Wilson School of Law; and... More
My company:
Marketocracy capital management
My blog:
Barchart Portfolio Blogs
  • Celldex Therapeutics - Chart Of The Day  0 comments
    Sep 24, 2013 4:29 PM | about stocks: CLDX

    Celldex Therapeutics (NASDAQ:CLDX) is the Chart of the Day. The stock has both a Trend Spotter buy and 100% Barchart technical buy signals. I found the stock by sorting the New High List for Weighted Alpha and the stocks was 437.10+

    It is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.

    (click to enlarge)

    Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

    Barchart technical indicators:

    • 100% Barchart technical buy signals
    • Trend Spotter buy signal
    • Above its 20, 50 and 100 day moving averages
    • 9 new highs and up 43.54% in the last month
    • Relative strength Index 85.67%
    • Barchart computes a technical support level at 28.17
    • Recently traded at 33.87 with a 50 day moving average of 22.54

    Fundamental factors:


    • I'm totally perplexed on the fundamentals
    • Revenue is predicted to have negative growth
    • Earnings are not only estimated to be negative but analysts expect the deficit to increase
    • In spite of that Wall Street analysts issued 7 Strong buy and 2 Buy recommendations
    • Financial Strength is B+

    My take is this is an interesting situation. The price is rising and analysts like it but at the same time they predict shrinking revenue and continuing losses. Monitor this but keep your powder dry.

    Stocks: CLDX
Back To Jim Van Meerten's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


  • $UFPI - 96% technical buy signals - 15 new highs and up 22.16% in the last month - Relative Strength Index 72.83%
    about 24 hours ago
  • $OFG - 96% technical buy signals - 15 new highs and up 23.03% in the last month - Relative Strength Index 75.19%
    about 24 hours ago
  • $SBRA - 80% technical buy signals - 15 new highs and up 17.97% in the last month - Relative Strength Index 70.75%
    about 24 hours ago
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.